2015
DOI: 10.1590/s1806-37132015000004493
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic value of endobronchial ultrasound-guided transbronchial needle aspiration in various lung diseases

Abstract: Objective: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a new method for the diagnosis and staging of lung disease, and its use is increasing worldwide. It has been used as a means of diagnosing lung cancer in its initial stages, and there are data supporting its use for the diagnosis of benign lung disease. The aim of this study was to share our experience with EBUS-TBNA and discuss its diagnostic value. Methods: We retrospectively analyzed the results related to 159 patient… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
23
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(23 citation statements)
references
References 21 publications
(55 reference statements)
0
23
0
Order By: Relevance
“…However, there are no recognized clinical indicators for lung cancer prevention, early diagnosis, and treatment. Therefore, early disease detection, improvement in treatment and prognosis, decrease in lung cancer incidence and mortality rates, as well as increase in survival rates are all important issues to tackle (Ortakoylu et al, 2015;Xiao et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…However, there are no recognized clinical indicators for lung cancer prevention, early diagnosis, and treatment. Therefore, early disease detection, improvement in treatment and prognosis, decrease in lung cancer incidence and mortality rates, as well as increase in survival rates are all important issues to tackle (Ortakoylu et al, 2015;Xiao et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…EBUS-TBNA is also successfully performed for diagnostic purposes in patients with paratracheal and peribronchial tumours [2,3].…”
Section: Introductionmentioning
confidence: 99%
“…Following an in-depth investigation of lung cancer biology and pathogenesis over previous years, there have been notable advances in the diagnosis and treatment of lung cancer. However, the identification of specific biomarkers for the early diagnosis and prognosis of lung cancer is still required (17). The most bioactive metabolite of vitamin D, 1α,25(OH) 2 D 3 has been confirmed to contribute various non-endocrine functions in addition to maintaining calcium stability; including anti-proliferative activity, induction of cell differentiation, promotion of cell cycle stagnation and apoptosis, inhibiting cytopoiesis and regulating tumor occurrence and development (18,19).…”
Section: Discussionmentioning
confidence: 99%